With AI Sophia Genetics has received a CE-IVD mark for its molecular diagnostics test, which will improve the detection of leukemia

Today, the company has received a CE-IVD mark for its molecular diagnostics tool, meaning it can be traded within the European single market. The technology reads the genome more precisely to improve the diagnosis of leukemia and boost the personalization of cancer care.


GUTE-URLS

Wordpress is loading infos from labiotech

Please wait for API server guteurls.de to collect data from
labiotech.eu/cancer-diagnos...